Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.
about
Treatment of early uterine sarcomas: disentangling adjuvant modalitiesAdjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcomaAdjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcomaAn uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case reportMalignant tumors of the female reproductive systemA gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.A retrospective study on combination therapy with ifosfamide, adriamycin and cisplatin for progressive or recurrent uterine sarcoma.Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives.Cervical Mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature.F-18 fluorodeoxyglucose positron emission tomography/computed tomography in a rare case of recurrent malignant mixed mullerian tumor.Diagnosis and treatment of sarcoma of the uterus. A review.Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma.Guess the case.T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2.Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGGUterine sarcoma. Clinico-pathological characteristics and outcome.Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma.Outcome analysis in patients with uterine sarcomaUterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrencePotential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy.A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature.Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma.The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.Uterine carcinosarcomas: 8-year single center experience of 25 casesUnexpected Leiomyosarcoma 4 Years after Laparoscopic Removal of the Uterus Using Morcellation.The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma.Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).Carcinosarcoma of the Rectum: Report of a Rare Colorectal Malignancy and Review of the Literature.Dedifferentiated leiomyosarcoma of the uterus with heterologous elements: a potential diagnostic pitfall.Genomic, Epigenomic, and Transcriptomic Profiling towards Identifying Omics Features and Specific Biomarkers That Distinguish Uterine Leiomyosarcoma and Leiomyoma at Molecular Levels.Giant leiomyosarcoma: A case reportThe etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium.Uterine leiomyosarcoma manifesting as a tricuspid valve mass.Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma.Endometrial stromal sarcoma: a population-based analysismicroRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report.Perivascular epithelioid tumours (PEComas) of the gynaecological tractHistopathologic differences account for racial disparity in uterine cancer survival.
P2860
Q21245577-E2437F36-08E7-4B81-A846-759AD64FF6DBQ24201005-EB96970F-316E-4CDC-9F0C-C1AE1C159C1EQ24234735-1A5B13C7-8B03-45DF-A175-0A4D0E90B9E6Q28076781-23C684E4-209D-4C73-A880-6505E8ED1D2AQ28388678-71313F2F-F10E-40BB-8543-EA95987FC331Q30438454-1628C7A8-962F-402E-869F-8DA5E0DB38ECQ33415973-DF7B57A0-1D71-4648-A373-11DAD3AC4DEAQ33563921-ABFBC2A4-033D-4B91-8D1B-69E22124FC2EQ33755476-31F30465-251A-43CB-89D0-DFC794C8736DQ33929694-7B76EBF0-1F49-4188-9551-DD25181F431FQ34111278-64B762A8-EA62-4182-9A38-07E576804CC3Q34336818-30121F65-AD8D-4EE6-8928-96F102FBCC5DQ34700785-DB887BE3-A6C3-431A-8B15-EA34D417C342Q34986173-AE8CEE5A-E7A3-4E9D-AE44-64CB9C1A2625Q35027806-B886D53C-4286-4624-A3AD-BC085CEB0EAEQ35180929-CDA728A8-5F1E-451D-A6D2-8472BDCBC7C0Q35183504-68C0134B-72EF-42B6-AE54-9DA9DFFB288CQ35345665-6D5EB140-1714-45E6-9912-C9572EDD69B6Q35375270-F666C7B7-F2E2-40AE-AB6C-8E47A728E597Q35601947-4F94E922-D00B-4C00-8DD6-4B39946CE645Q35619604-4D888085-BD7D-49DB-A107-4F23CD00DE33Q35688700-54FD8EEB-B120-46D0-B1D1-70A96CAF2877Q35731556-EA232C90-7B6D-484E-82E4-506E4358560AQ35738934-F9BA46FE-4BEC-44F9-89A9-CFCC21F3B019Q35810590-9508AE07-9F8C-448C-9CBB-143605454435Q35929671-5D5FDAE0-B53E-4E8D-94BC-E492FECEA5C9Q36150351-F637E889-F2D7-4918-B683-3D9A6D163271Q36225952-B4B87191-F1E7-4B10-AD48-00FA896D8747Q36295510-E93B4097-99F8-414D-8EB3-A8A29C9E5503Q36333116-148E3250-73A4-4273-B5F6-F45A47409FE8Q36355215-67F5693E-B62E-4045-9C26-7CCA3B58617FQ36448418-C52AF9C5-15B0-42D2-8957-51A8F0BFC9D9Q36587263-8FA42D3B-893B-4A8A-9320-C88137554F6DQ36671946-FECC663B-1864-4B75-8DDB-0F5DD0E406D3Q36744460-339D0265-B35F-4778-ACE3-93B16907A12EQ36922697-44C9339F-C789-4EF4-802F-F3C121C3E118Q36943983-FED4BFDE-14C9-48C7-8C20-5CECF82EEC3BQ37018743-E1C0EAC9-F065-43CF-B957-F107B4FF4B0CQ37173539-03589A7E-84B4-4750-9D87-66B6EF3F136CQ37310924-9D253BFD-BA75-4571-8AE3-68385C872F01
P2860
Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Surveillance, epidemiology, an ...... of uterine sarcoma 1989-1999.
@en
Surveillance, epidemiology, an ...... of uterine sarcoma 1989-1999.
@nl
type
label
Surveillance, epidemiology, an ...... of uterine sarcoma 1989-1999.
@en
Surveillance, epidemiology, an ...... of uterine sarcoma 1989-1999.
@nl
prefLabel
Surveillance, epidemiology, an ...... of uterine sarcoma 1989-1999.
@en
Surveillance, epidemiology, an ...... of uterine sarcoma 1989-1999.
@nl
P2093
P1433
P1476
Surveillance, epidemiology, an ...... of uterine sarcoma 1989-1999.
@en
P2093
Claudia R Baquet
Sandra E Brooks
Timothy Cote
P304
P356
10.1016/J.YGYNO.2003.12.029
P407
P577
2004-04-01T00:00:00Z